Degenerative terminals of the perforant pathway are human α-synuclein- immunoreactive in the hippocampus of patients with diffuse Lewy body disease

Neuroscience Letters

Volumn 258, Issue 2, 1998, Pages 81-84

  Iseki, Eizo ^a   Marui, Wami ^a   Kosaka, Kenji ^a   Akiyama, Haruhiko ^b   Ueda, Kenji ^b   Iwatsubo, Takeshi ^c  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Synuclein; Diffuse Lewy body disease; Hippocampus; Immunohistochemistry; Perforant pathway; Ubiquitin

Indexed keywords

UBIQUITIN;

ALZHEIMER DISEASE; ARTICLE; CYTOSKELETON; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; NERVE DEGENERATION; NERVE ENDING; PRIORITY JOURNAL;

AGED; ALPHA-SYNUCLEIN; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PERFORANT PATHWAY; PHOSPHOPROTEINS; PRESYNAPTIC TERMINALS; SYNUCLEINS; TEMPORAL LOBE; UBIQUITINS;

EID: 0032545154     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00856-8     Document Type: Article

References (18)

1. Baba, M., Nakajo, S., Tu, P.-H., Tomita, T., Nakaya, K., Lee, V.M.-Y., Trojanowski, L.Q. and Iwatsubo, T., Aqgregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies, Am. J. Pathol., 152 (1998) 879-884.
2. Dickson, D.W., Schmidt, M.L., Lee, V.M.-Y., Zhao, M.-L., Yen, S.-H. and Trojanowski, J.Q., Immunoreactivity profile of hippocampal CA2-3 neurites in diffuse Lewy body disease, Acta Neuropathol., 87 (1994) 269-276.
3. Duffy, P. and Tennyson, V.R., Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus ceruleus in Parkinson's disease, J. Neuropathol. Exp. Neurol., 24 (1965) 398-414.
4. Hyman, B.T., Van Hoesen, G.W., Kromer, L.J. and Damasio, A.R., Perforant pathway changes and the memory impairment of Alzheimer's disease, Ann. Neurol., 20 (1986) 472-481.
5. Iseki, E., Li, F., Odawara, T. and Kosaka, K., Hippocampal pathology in diffuse Lewy body disease using ubiquitin immunohistochemistry, J. Neurol. Sci., 149 (1997) 165-169.
6. Ishimaru, H., Ueda, K., Takahashi, A. and Maruyama, Y., Changes in presynaptic protein NACP/α-synuclein in an ischemic gerbil hippocampus, Brain Res., 788 (1998) 311-314.
7. Iwai, A., Masliah, E., Yoshimoto, M., De Silva, R., Ge, N., Kittel, A. and Saito, T., The precursor protein of non-Aβ component of Alzheimer's disease amyloid (NACP) is a presynaptic protein of the central nervous system, Neuron, 14 (1994) 467-475.
8. Kosaka, K., Diffuse Lewy body disease in Japan, J. Neurol., 237 (1990) 197-204.
9. Kuzuhara, S., Mori, H., Izumiyama, N., Yoshimura, M. and Ihara, Y., Lewy bodies are ubiquitinated: a light and electron microscopic immunocytochemical study, Acta Neuropathol., 75 (1988) 345-353.
10. Masliah, E., Iwai, A., Mallory, M., Ueda, K. and Saito, T., Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease, Am. J. Pathol., 148 (1996) 201-210.
11. McKeith, I.G., Galasko, D., Kosaka, K., Perry, E.K., Dickson, D.W., Hansen, L.A., Salmon, D.P., Lowe, J., Mirra, S.S., Byrne, E.J., Lennox, G., Quinn, N.P., Edwardson, J.A., Ince, P.G., Bergeron, C., Burns, A., Miller, B.L., Lovestone, S., Collerton, D., Jansen, E.N.H., Ballard, C., de Vos, R.A.I., Wilcock, G.K., Jellinger, K.A. and Perry, R.H., Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop, Neurology, 47 (1996) 1113-1124.
12. Mizutani, T. and Kasahara, M., Degeneration of the intrahippocampal routes of the perforant and alveolar pathways in senile dementia of Alzheimer type, Neurosci. Lett., 184 (1995) 141-144.
13. Polymeropoulos, M.H., Lavedant, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W.G., Lazzarini, A.M., Duvoisin, R.C., De Iorio, G., Golbe, L.I. and Nussbaum, R.L., Mutation in the α-synuclein gene identified in families with Parkinson's disease, Science, 276 (1997) 2045-2047.
14. Schmidt, M.L., Murray, J., Lee, V.M.-Y., Hill, W.D., Wertkin, A. and Trojanowski, J.Q., Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies, Am. J. Pathol., 139 (1991) 53-65.
15. Spillantini, M.G., Schmidt, M.L., Lee, V.M.-Y., Trojanowski, J.Q., Jakes, R. and Goedert, M., α-Synuclein in Lewy bodies, Nature, 388 (1997) 839-840.
16. Takeda, A., Mallory, M., Sundsmo, M., Honer, W., Hansen, L. and Masliah, E., Abnormal accumulation of NACP/α-synuclein in neurodegerative disorders, Am. J. Pathol., 152 (1998) 367-372.
17. Trojanowski, J.Q. and Lee, V.M.-Y., Aggregation of neurofilament and α-synuclein proteins in Lewy bodies, Arch. Neurol., 55 (1998) 151-152.
18. Wakabayashi, R., Matsumoto, K., Takayama, K., Yoshimoto, M. and Takahashi, H., NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease, Neurosci. Lett., 239 (1997) 45-48.